To view the clinical trials Valley currently has available, please use the search field or select a clinical specialty from the drop-down list below. Be sure to check back frequently, as we are always adding new studies.
For more information about any of our clinical trials, please email [email protected] or call 201-447-8453. (For cancer clinical trials, please call 201-634-5792.)
LEFT ATRIAL APPENDAGE LIGATION WITH THE LARIAT™ SUTURE DELIVERY SYSTEM AS ADJUNCTIVE THERAPY TO PULMONARY VEIN ISOLATION FOR PERSISTENT OR LONGSTANDING PERSISTENT ATRIAL FIBRILLATION
Principal Investigator(s): Dan L. Musat, MD
Status: Closed to Enrollment, Patients in Follow-Up
Apixaban for the Reduction of Thrombo-Embolism in patients with Device-Detected Sub-Clinical Atrial Fibrillation
Principal Investigator(s): Suneet Mittal, MD
Status: Closed to Enrollment, Patients in Follow-Up
Relationship Between Wrist-based PPG and Patch ECG Assessments of Cardiac Rhythm
Principal Investigator(s): Suneet Mittal, MD
Status: Closed to Enrollment, No Patients in Follow-Up
BATwire Implant Kit
Principal Investigator(s): Suneet Mittal, MD
Status: Open and enrolling
Pragmatic Randomized Clinical Trial of Early Dronedarone Versus Usual Care to Change and Improve Outcomes in Persons With First-Detected Atrial Fibrillation
Principal Investigator(s): Dan L. Musat, MD
Status: Open and enrolling
Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry (CONFIRM2)
Principal Investigator(s): Himanshu Gupta, MD
Status: Open and enrolling
Impact of a Structured Cardiac Rehabilitation Program on Cardiorespiratory Fitness in Patients with Atrial Fibrillation
Principal Investigator(s): Suneet Mittal, MD
Status: Open and enrolling
The purpose of this study is to evaluate the association between complex patterns of device-detected AF and other summary and episodic measurements collected by the LINQ ICM device and AF-related healthcare utilization, quality of life, AF-related symptoms, and specific clinical outcomes in patients with a market-released LINQ ICM.
Principal Investigator(s): Dan L. Musat, MD
Status: Open and enrolling
Anti-Heart Antibodies Can Predict Early Development of Dressler/s Syndrome After Hybrid Ablation
Principal Investigator(s): Tina C. Sichrovsky, MD
Status: Closed to Enrollment, Patients in Follow-Up
A Randomized Noninferiority Study of the TYRX-A Antibacterial Envelope Alone Versus Envelope Plus Intraoperative Antibacterial Irrigant and Postoperative Oral Antibiotics to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Patients
Principal Investigator(s): Suneet Mittal, MD
Status: Closed to Enrollment, No Patients in Follow-Up